Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes

被引:172
|
作者
Smith-Palmer, J. [1 ]
Braendle, M. [2 ]
Trevisan, R. [3 ]
Federici, M. Orsini [4 ]
Liabat, S. [5 ]
Valentine, W. [1 ]
机构
[1] Ossian Hlth Econ & Commun, CH-4051 Basel, Switzerland
[2] Kantonsspital St Gallen, St Gallen, Switzerland
[3] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[4] SpA, Medtron Italia, Milan, Italy
[5] Medtron Int Trading Sarl, Tolochenaz, Switzerland
关键词
Glycemic variability; Microvascular complications; Macrovascular complications; FASTING PLASMA-GLUCOSE; CORONARY-ARTERY-DISEASE; MEAN BLOOD-GLUCOSE; HBA(1C) VARIABILITY; MICROVASCULAR COMPLICATIONS; CARDIOVASCULAR-DISEASE; RISK-FACTOR; INDEPENDENT CORRELATE; CHRONIC HYPERGLYCEMIA; RENAL-INSUFFICIENCY;
D O I
10.1016/j.diabres.2014.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic hyperglycemia is the main risk factor for the development of diabetes-related complications in both type 1 and type 2 diabetes, but it is thought that frequent or large glucose fluctuations may contribute independently to diabetes-related complications. A systematic literature review was performed using the PubMed, EMBASE and Cochrane Library databases with searches limited to studies published from June 2002 to March 2014, in English and including >= 50 patients. Twenty eight articles were included in the final review. Eighteen studies reported the association between glucose variability and diabetes-related complications exclusively in type 2 diabetes. A positive association between increased variability and microvascular complications and coronary artery disease was consistently reported. Associations between glucose variability and other macrovascular complications were inconsistent in type 2 diabetes. Seven studies examined the association between glucose variability and complications exclusively in type 1 diabetes. Increased glucose variability appears to play a minimal role in the development of micro- and macrovascular complications in type 1 diabetes. Consistent findings suggest that in type 2 diabetes glucose variability is associated with development of microvascular complications. The role of increased glucose variability in terms of microvascular and macrovascular complications in type 1 diabetes is less clear; more data in are needed. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:273 / 284
页数:12
相关论文
共 50 条
  • [41] Complications of Type 1 Diabetes
    Melendez-Ramirez, L. Yvonne
    Richards, Robert J.
    Cefalu, William T.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (03) : 625 - +
  • [42] Physiologic Characterization of Type 2 Diabetes-Related Loci
    Grarup, Niels
    Sparso, Thomas
    Hansen, Torben
    CURRENT DIABETES REPORTS, 2010, 10 (06) : 485 - 497
  • [43] Glycated hemoglobin variability and microvascular complications in patients with type 1 diabetes mellitus
    Er, Eren
    Ata, Aysun
    Evin, Ferda
    Altinok, Yasemin Atik
    Demir, Gunay
    Ozen, Samim
    Darcan, Sukran
    Goksen, Damla
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (12) : 1533 - 1537
  • [44] Gut Microbiota and Complications of Type-2 Diabetes
    Iatcu, Camelia Oana
    Steen, Aimee
    Covasa, Mihai
    NUTRIENTS, 2022, 14 (01)
  • [45] Association of glycemic variability and hypoglycemia with distal symmetrical polyneuropathy in adults with type 1 diabetes
    Shen, Ziyang
    Jiang, Hemin
    Huang, Rong
    Zhou, Yunting
    Li, Qian
    Ma, Jianhua
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] Analysis of the Incidence of Type 2 Diabetes, Requirement of Insulin Treatment, and Diabetes-Related Complications among Patients with Cancer
    Lee, Su Jung
    Kim, Chulho
    Yu, Hyunjae
    Kim, Dong-Kyu
    CANCERS, 2023, 15 (04)
  • [47] Clinical implications and pharmacological considerations of glycemic variability in patients with type 2 diabetes mellitus
    Howsawi, Alanood A.
    Alem, Manal M.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [48] Glycemic variability predicts inflammation in adolescents with type 1 diabetes
    Hoffman, Robert P.
    Dye, Amanda S.
    Huang, Hong
    Bauer, John A.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2016, 29 (10) : 1129 - 1133
  • [49] Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus
    Shun Yokota
    Hidekazu Tanaka
    Yasuhide Mochizuki
    Fumitaka Soga
    Kentaro Yamashita
    Yusuke Tanaka
    Ayu Shono
    Makiko Suzuki
    Keiko Sumimoto
    Jun Mukai
    Makiko Suto
    Hiroki Takada
    Kensuke Matsumoto
    Yushi Hirota
    Wataru Ogawa
    Ken-ichi Hirata
    Cardiovascular Diabetology, 18
  • [50] The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes-related and cancer outcomes
    Riley, David R.
    Henney, Alex
    Anson, Matthew
    Hernadez, Gema
    Zhao, Sizheng S.
    Alam, Uazman
    Wilding, John P. H.
    Craig, Sonya
    Cuthbertson, Daniel J.
    DIABETES OBESITY & METABOLISM, 2024, : 663 - 674